|Bid||0.0300 x 0|
|Ask||0.0350 x 0|
|Day's Range||0.0300 - 0.0300|
|52 Week Range||0.0100 - 0.0700|
|Beta (5Y Monthly)||-2.17|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, British Columbia, July 06, 2020 -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) wishes to amend its news release dated July 2, 2020 in which it.
AVRICORE HEALTH INC. (AVCR.V) (the "Company" or “AVCR”) is pleased to announce that it has entered into shares for debt agreements, to satisfy an aggregate of $126,949 of the Company’s outstanding debts. The Company has reached agreements with certain of its creditors who have provided services to the Company to extinguish, or partially extinguish, certain of the Company’s outstanding debts owing to them in exchange for the issuance of common shares ("Shares") of the Company. The creditors include certain related parties of the Company, including Hector Bremner, the Company’s CEO, Bob Rai, the Company's President and Rodger Seccombe, the Company's Chief Technology Officer (collectively, the "Related Parties").
While the world deals with the impacts of COVID-19, Avricore Health has utilized its network of suppliers and customers and Health Canada Licences to drive interim revenues. VANCOUVER, British Columbia, June 29, 2020 (GLOBE NEWSWIRE) -- Avricore Health (AVCR.V), like so many other business, has faced both challenges and opportunities over the past several weeks. Thankfully, we’ve not had any team members sick, however, one close partner did spend time in hospital, bringing this health crisis close to home.